BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 34543537)

  • 1. Use of the «BCR/ABL - multitest» kit in the algorithm of laboratory diagnostics of oncohematological diseases: economic aspects.
    Gorbenko AS; Stolyar MA; Vasiliev EV; Mikhalev MA; Bakhtina VI; Olkhovik TI; Mochalova EE; Orlova KE; Olkhovskiy IA
    Klin Lab Diagn; 2021 Sep; 66(9):571-576. PubMed ID: 34543537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BCR/ABL p210, p190 and p230 fusion genes in 250 Mexican patients with chronic myeloid leukaemia (CML).
    Arana-Trejo RM; Ruíz Sánchez E; Ignacio-Ibarra G; Báez de la Fuente E; Garces O; Gómez Morales E; Castro Granados M; Ovilla Martínez R; Rubio-Borja ME; Solís Anaya L; Herrera P; Delgado Llamas J; Kofman S
    Clin Lab Haematol; 2002 Jun; 24(3):145-50. PubMed ID: 12067277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p190 BCR-ABL mRNA is expressed at low levels in p210-positive chronic myeloid and acute lymphoblastic leukemias.
    van Rhee F; Hochhaus A; Lin F; Melo JV; Goldman JM; Cross NC
    Blood; 1996 Jun; 87(12):5213-7. PubMed ID: 8652835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity.
    Li S; Ilaria RL; Million RP; Daley GQ; Van Etten RA
    J Exp Med; 1999 May; 189(9):1399-412. PubMed ID: 10224280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-B acute lymphoblastic leukemia with b3a2 (p210) and e1a2 (p190) BCR-ABL fusion transcripts relapsing as chronic myelogenous leukemia with a less differentiated b3a2 (p210) clone.
    Winter SS; Greene JM; McConnell TS; Willman CL
    Leukemia; 1999 Dec; 13(12):2007-11. PubMed ID: 10602422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of p210 and p190 BCR-ABL due to alternative splicing in chronic myelogenous leukaemia.
    Lichty BD; Keating A; Callum J; Yee K; Croxford R; Corpus G; Nwachukwu B; Kim P; Guo J; Kamel-Reid S
    Br J Haematol; 1998 Dec; 103(3):711-5. PubMed ID: 9858221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular analysis of lineage-specific chimerism and minimal residual disease by RT-PCR of p210(BCR-ABL) and p190(BCR-ABL) after allogeneic bone marrow transplantation for chronic myeloid leukemia: increasing mixed myeloid chimerism and p190(BCR-ABL) detection precede cytogenetic relapse.
    Serrano J; Roman J; Sanchez J; Jimenez A; Castillejo JA; Herrera C; Gonzalez MG; Reina L; Rodriguez MC; Alvarez MA; Maldonado J; Torres A
    Blood; 2000 Apr; 95(8):2659-65. PubMed ID: 10753848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the clinico-hematological relevance of the breakpoint location within M-BCR in chronic myeloid leukemia.
    Bennour A; Ouahchi I; Achour B; Zaier M; Youssef YB; Khelif A; Saad A; Sennana H
    Med Oncol; 2013 Mar; 30(1):348. PubMed ID: 23269583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of BCR-ABL fusion transcripts in Iranian patients with chronic myeloid leukemia.
    Yaghmaie M; Ghaffari SH; Ghavamzadeh A; Alimoghaddam K; Jahani M; Mousavi SA; Irvani M; Bahar B; Bibordi I
    Arch Iran Med; 2008 May; 11(3):247-51. PubMed ID: 18426313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiplex in-cell reverse transcription-polymerase chain reaction for the simultaneous detection of p210 and p190 BCR-ABL mRNAs in chronic myeloid leukemia and Philadelphia-positive acute lymphoblastic leukemia cell lines.
    Suh SP; Kee SJ; Lim WH; Song JW; Lee SK; Kim JP; Shin JH; Ryang DW
    Clin Chem Lab Med; 2000 Sep; 38(9):939-44. PubMed ID: 11097354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sequential analysis of p210- and p190-bcr-abl by RT-PCR after allogeneic bone marrow transplantation for p210/p190-bcr-abl double positive acute lymphoblastic leukemia].
    Fujimaki K; Maruta A; Yoshida M; Yamazaki E; Motomura S; Kodama F; Matsuzaki M; Fujisawa S; Kanamori H; Ishigatsubo Y
    Rinsho Ketsueki; 2001 Feb; 42(2):89-93. PubMed ID: 11280922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Application of Real-time Quantitative PCR in Detecting Atypical BCR/ABL mRNA Transcripts in Chronic Myelocytic Leukemia].
    Zou Y; DU C; Chen HM; Guo FX; Cheng JB; Tang YY; Wu W; Xia CQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Aug; 25(4):1016-1021. PubMed ID: 28823261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single monochrome real-time RT-PCR assay for identification, quantification, and breakpoint cluster region determination of t(9;22) transcripts.
    Gutiérrez MI; Timson G; Siraj AK; Bu R; Barbhaya S; Banavali S; Bhatia K
    J Mol Diagn; 2005 Feb; 7(1):40-7. PubMed ID: 15681473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Philadelphia chromosome-positive chronic myeloid leukemia expressing p190(BCR-ABL).
    Ohsaka A; Shiina S; Kobayashi M; Kudo H; Kawaguchi R
    Intern Med; 2002 Dec; 41(12):1183-7. PubMed ID: 12521212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TaqMan RT-PCR assay coupled with capillary electrophoresis for quantification and identification of bcr-abl transcript type.
    Luthra R; Sanchez-Vega B; Medeiros LJ
    Mod Pathol; 2004 Jan; 17(1):96-103. PubMed ID: 14657955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic myeloid leukemia presenting ALL-type BCR/ABL transcript.
    Kunieda Y; Okabe M; Kurosawa M; Itaya T; Kakinuma M; Miyazaki T
    Ann Hematol; 1994 Oct; 69(4):189-93. PubMed ID: 7948305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is p190 bcr-abl rearrangement necessary for acute transformation in some p210 CML of childhood?
    Scrideli CA; de Oliveira FM; Brassesco MS; de Paula Queiroz R; Bernardes JE; Valera ET; Tone LG
    Leuk Res; 2009 Mar; 33(3):495-9. PubMed ID: 18495245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consistent amounts of acute leukemia-associated P190BCR/ABL transcripts are expressed by chronic myelogenous leukemia patients at diagnosis.
    Saglio G; Pane F; Gottardi E; Frigeri F; Buonaiuto MR; Guerrasio A; de Micheli D; Parziale A; Fornaci MN; Martinelli G; Salvatore F
    Blood; 1996 Feb; 87(3):1075-80. PubMed ID: 8562932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The presence of typical and atypical BCR-ABL fusion genes in leukocytes of normal individuals: biologic significance and implications for the assessment of minimal residual disease.
    Bose S; Deininger M; Gora-Tybor J; Goldman JM; Melo JV
    Blood; 1998 Nov; 92(9):3362-7. PubMed ID: 9787174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic Myelogenous Leukemia with Double Philadelphia Chromosome and Coexpression of p210 and p190 Fusion Transcripts.
    Cruz SSD; Seabra AD; Macambira LHR; Carneiro DM; Nunes PF; Pontes TB; Mello-Junior FAR; Leão LBC; Cordeiro FNCDS; Carneiro TX; Moreira-Nunes CA; Burbano RMR
    Genes (Basel); 2022 Mar; 13(4):. PubMed ID: 35456386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.